Twist Bioscience Ownership | Who Owns Twist Bioscience?


OverviewForecastRevenueFinancialsChartTranscripts

Twist Bioscience Ownership Summary


Twist Bioscience is owned by 124.56% institutional investors, 1.08% insiders. Vanguard group is the largest institutional shareholder, holding 9.46% of TWST shares. EdgePoint Global Portfolio Series F is the top mutual fund, with 4.51% of its assets in Twist Bioscience shares.

TWST Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockTwist Bioscience124.56%1.08%-25.65%
SectorHealthcare Stocks 244.59%12.11%-156.70%
IndustryBiotech Stocks 379.61%11.70%-291.31%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Vanguard group5.78M9.46%$183.22M
Blackrock funding, inc. /de5.83M9.45%$600.19M
Blackrock5.42M9.33%$267.28M
Artisan partners limited partnership4.80M7.78%$494.03M
Fmr4.70M7.62%$483.85M
Ark investment management4.55M7.37%$468.08M
Price t rowe associates inc /md/3.63M5.89%$373.93M
State street3.23M5.24%$332.56M
Vanguard capital management2.70M4.37%$277.70M
Edgepoint investment group2.52M4.09%$259.43M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Metavasi capital lp176.00K6.32%$18.11M
Freshford capital management177.45K6.25%$18.26M
First light asset management727.93K4.55%$74.89M
Ark investment management4.55M3.04%$468.08M
Seaport global advisors15.95K2.81%$785.97K
Tao capital management lp478.81K2.54%$49.26M
Science & technology partners129.23K2.24%$13.29M
Edgepoint investment group2.52M1.96%$259.43M
Highmark wealth management39.03K1.35%$4.02M
Nikko asset management americas999.73K1.33%$102.84M

Top Buyers

HolderShares% AssetsChange
Price t rowe associates inc /md/3.63M0.04%3.56M
Fmr4.70M0.02%2.81M
D. e. shaw1.19M0.06%1.14M
Stephens investment management group767.36K0.85%767.36K
Farallon capital management2.14M1.01%708.75K

Top Sellers

HolderShares% AssetsChange
William blair investment management2.17M0.67%-3.10M
Edgepoint investment group2.52M1.96%-2.86M
Ark investment management4.55M3.04%-1.79M
Artisan partners limited partnership4.80M0.78%-1.57M
Soleus capital management104.63K0.37%-1.12M

New Positions

HolderShares% AssetsChangeValue
Stephens investment management group767.36K0.85%767.36K$78.95M
Fil641.10K0.05%641.10K$65.96M
T. rowe price investment management597.93K0.04%597.93K$61.52M
Sixth street partners management company557.13K0.01%557.13K$57.32M
Marshall wace, llp396.91K0.03%396.91K$40.83M

Sold Out

HolderChange
Turning point benefit group-1.00
Aster capital management (difc)-1.00
Tfc financial management-1.00
Jfs wealth advisors-1.00
Mather group, llc.-2.00

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Jun 30, 202634420.28%76,858,005-0.20%1240.78%19029.25%10114.77%
Mar 31, 2026132-47.20%23,630,692-68.50%380.26%62-50.40%39-50.63%
Dec 31, 2025175-27.08%52,689,047-28.59%860.57%89-33.58%49-20.97%
Sep 30, 2025228-4.20%73,141,5369.76%1210.99%12714.41%59-32.18%
Jun 30, 2025242-8.33%69,840,7412.16%1160.89%112-17.65%867.50%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
EdgePoint Global Portfolio Series F2.81M4.51%661.14K
EdgePoint Global2.81M4.51%661.14K
ARK Disruptive Innovation Full Composite2.40M3.86%-1.15M
ARK Innovation ETF2.01M3.21%-19.29K
Vanguard Total Stock Mkt Idx Inv1.87M3.01%18.38K
Vanguard Morn Total Stk Mkt Idx Investor1.87M3.01%18.38K
Vanguard MStar Total Stk Mkt Idx Invest1.88M3.00%6.20K
Vanguard US Total Market Shares ETF1.74M2.92%1.75K
iShares Russell 2000 ETF1.57M2.53%-27.94K
ARK Genomic Revolution1.51M2.42%-450.83K

Recent Insider Transactions


DateNameRoleActivityValue
Aug 25, 2026Leproust Emily M. Chief Executive OfficerSell$1.41M
Aug 25, 2026Leproust Emily M. Chief Executive OfficerSell$1.85M
Aug 25, 2026Leproust Emily M. Chief Executive OfficerSell$1.90M
Aug 25, 2026Leproust Emily M. Chief Executive OfficerSell$979.43K
Aug 25, 2026Leproust Emily M. Chief Executive OfficerSell$168.81K

Insider Transactions Trends


DateBuySell
2026 Q3-32
2026 Q2-46
2026 Q1-35
2025 Q4-39
2025 Q3-26

TWST Ownership FAQ


Who Owns Twist Bioscience?

Twist Bioscience shareholders are primarily institutional investors at 124.56%, followed by 1.08% insiders and -25.64% retail investors. The average institutional ownership in Twist Bioscience's industry, Biotech Stocks , is 379.61%, which Twist Bioscience falls below.

Who owns the most shares of Twist Bioscience?

Twist Bioscience’s largest shareholders are Vanguard group (5.78M shares, 9.46%), Blackrock funding, inc. /de (5.83M shares, 9.45%), and Blackrock (5.42M shares, 9.33%). Together, they hold 28.24% of Twist Bioscience’s total shares outstanding.

Does Blackrock own Twist Bioscience?

Yes, BlackRock owns 9.33% of Twist Bioscience, totaling 5.42M shares as of Jun 2024. This represents 0.01% of BlackRock's total assets, with a market value of 267.28M$. In the last quarter, BlackRock decreased its holdings by -351K shares, a -6.08% change.

Who is Twist Bioscience’s biggest shareholder by percentage of total assets invested?

Metavasi capital lp is Twist Bioscience’s biggest shareholder by percentage of total assets invested, with 6.32% of its assets in 176K Twist Bioscience shares, valued at 18.11M$.

Who is the top mutual fund holder of Twist Bioscience shares?

EdgePoint Global Portfolio Series F is the top mutual fund holder of Twist Bioscience shares, with 4.51% of its total shares outstanding invested in 2.81M Twist Bioscience shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools